0.1288
Precedente Chiudi:
$0.134
Aprire:
$0.1333
Volume 24 ore:
588.58K
Relative Volume:
0.25
Capitalizzazione di mercato:
$15.38M
Reddito:
$436.97M
Utile/perdita netta:
$-35.62M
Rapporto P/E:
-0.4316
EPS:
-0.2983
Flusso di cassa netto:
$-10.71M
1 W Prestazione:
-17.31%
1M Prestazione:
-42.90%
6M Prestazione:
-71.58%
1 anno Prestazione:
-91.90%
Accuray Inc Stock (ARAY) Company Profile
Nome
Accuray Inc
Settore
Industria
Telefono
608-824-2800
Indirizzo
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ARAY
Accuray Inc
|
0.1288 | 15.38M | 436.97M | -35.62M | -10.71M | -0.2983 |
|
ABT
Abbott Laboratories
|
102.95 | 178.15B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
95.96 | 122.75B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
308.54 | 118.35B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
45.52 | 65.98B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.33 | 51.49B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-05-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-02-13 | Iniziato | ROTH MKM | Buy |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Loop Capital | Buy |
| 2020-01-21 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-11-01 | Aggiornamento | Citigroup | Sell → Neutral |
| 2017-12-13 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Iniziato | Lake Street | Buy |
| 2016-12-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Iniziato | Citigroup | Sell |
| 2015-05-01 | Reiterato | Dougherty & Company | Buy |
| 2015-01-12 | Iniziato | Northland Capital | Outperform |
| 2014-01-31 | Reiterato | Dougherty & Company | Buy |
| 2014-01-29 | Reiterato | Brean Capital | Buy |
| 2013-11-11 | Reiterato | Dougherty & Company | Buy |
| 2013-08-29 | Reiterato | Dougherty & Company | Buy |
| 2011-09-20 | Reiterato | Ticonderoga | Buy |
| 2010-02-08 | Aggiornamento | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Aggiornamento | UBS | Sell → Neutral |
| 2009-03-09 | Downgrade | Soleil | Buy → Hold |
| 2009-01-30 | Aggiornamento | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Reiterato | Jefferies & Co | Hold |
| 2008-08-20 | Reiterato | Jefferies & Co | Hold |
Mostra tutto
Accuray Inc Borsa (ARAY) Ultime notizie
Accuray Incorporated (ARAY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026 - TradingView
Accuray Inc. R (XEJ.DU) Q3 FY2026 earnings call transcript - Yahoo Finance
Accuray Inc. R (XEJ.DU) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 4 Accuray Incorporated: Ali Pervaiz (SVP Chief Financial Officer) For: 23 September - Investing.com Nigeria
Accuray Inc : Jefferies Raises Target Price t - Moomoo
Accuray Incorporated Announces Mika Nishimura Not to Stand for Re-Election as Board of Directors - www.marketscreener.com
Accuray Director Richard Meier Awarded 75,000 RSUs and Stock Options in October 2026 - Kalkine Media
Accuray Announces Stockholder Approval of Key - Moomoo
Accuray Inc (ARAY) Stockholders Approve Key Financing and Revers - GuruFocus
Accuray appoints Richard A. Meier to Board and Compensation Committee - TradingView
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director - PR Newswire
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director - TradingView
Accuray Incorporated Announces Appointment of Richard A. ("Randy") Meier as Director and Compensation Committee Member, Effective October 6, 2026 - www.marketscreener.com
XEJ Forecast — Price Target — Prediction for 2027 - TradingView
Japan Approves Accuray’s Cyberknife M6 System for Radiation Therapy Patients - mpo-mag.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Accuray shares jump as Samsung NeuroLogica collaboration update sparks rally - Quiver Quantitative
Accuray Incorporated Stock Analysis: Bearish Trends and Key Levels Near Term - The Cryptonomist
Why Is Accuray Stock Gaining Monday? - Benzinga
Why Is Accuray Stock Gaining Monday? - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why is Accuray Incorporated Stock (ARAY) Up 60% Today? - TipRanks
Accuray partners with Samsung NeuroLogica on CyberKnife imaging - Medical Device Network
Accuray partners with Samsung NeuroLogica on CyberKnife imaging - finance.yahoo.com
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - Investing News Network
Accuray (ARAY) Partners with Samsung HME America to Advance Cybe - GuruFocus
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - PR Newswire
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - cherokeephoenix.org
Accuray Incorporated (ARAY) Partners With Samsung NeuroLogica on Volumetric Imaging for CyberKnife - tradingview.com
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - WAOW
Accuray Incorporated (ARAY) options chain - Yahoo Finance UK
ACCURAY INC SEC Filing (Sep 14, 2026) - Stock Titan
Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy - Bitget
Accuray And Raysearch Agree To Collaboration Integrating Raystation Software - TradingView
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - TradingView
Accuray and RaySearch agree to collaboration integrating RayStation software with Accuray platforms to accelerate Accuray’s online adaptive capabilities - TradingView
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - PR Newswire
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - Investing News Network
Accuray (NASDAQ: ARAY) clears 6.8M shares for investors to resell - Stock Titan
TCW GROUP INC Adds to Accuray Inc (ARAY) Stake -- Shares Trade 7 - GuruFocus
Accuray Stock Price Forecast. Should You Buy ARAY? - StockInvest.us
Accuray Inc (NASDAQ: ARAY) Discloses 18.7% Beneficial Ownership by TCW Including Warrants - Kalkine Media
Accuray | 4: Statement of changes in beneficial ownership of securities-10% Owner TCW GROUP INC - Moomoo
[SCHEDULE 13D/A] ACCURAY INC Amended Major Shareholder Report - Stock Titan
Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter - Yahoo Finance
Accuray Inc FY 2026: Revenue $401.95M, EPS ($0.4) — 10-K Summary - TradingView
Accuray (ARAY) sends definitive proxy to shareholders - Stock Titan
Penny-priced Accuray (NASDAQ: ARAY) warrants set up lender share resales - Stock Titan
Accuray Inc - TradingKey
Accuray Inc Azioni (ARAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Accuray Inc Azioni (ARAY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Peralta Leonel | SVP, Chief Operations Officer |
Feb 28 '26 |
Option Exercise |
0.00 |
83,723 |
0 |
83,723 |
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
| Kill Robert | Former Director |
Dec 22 '25 |
Proposed Sale |
0.92 |
262,809 |
241,784 |
0 |
| Chew Jesse | Officer |
Dec 01 '25 |
Proposed Sale |
1.02 |
19,993 |
20,393 |
0 |
| Winter Suzanne C | Officer |
Dec 01 '25 |
Proposed Sale |
1.02 |
68,058 |
69,419 |
0 |
| Pervaiz Ali | SVP Chief Financial Officer |
Nov 29 '25 |
Option Exercise |
0.00 |
44,025 |
0 |
410,204 |
| Chalke Sandeep | SVP, Chief Commercial Officer |
Nov 29 '25 |
Option Exercise |
0.00 |
50,314 |
0 |
524,283 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):